TY - JOUR T1 - Localised chronic eyelid disease resulting from long term hydroxyurea therapy JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 371 LP - 371 DO - 10.1136/bjo.85.3.371b VL - 85 IS - 3 AU - P PURI AU - B E WOODCOCK AU - N P O'DONNELL Y1 - 2001/03/01 UR - http://bjo.bmj.com/content/85/3/371.3.abstract N2 - Editor,—Hydroxyurea is an antineoplastic agent used in the treatment of various myelproliferative conditions and severe psoriasis. Documented skin manifestations from long term therapy with hydroxyurea include icthyosis, a dermatomyositis-like eruption on the dorsal hands, facial erythema, and accelerated development of premalignant and malignant skin lesions.1-5 Our patient is the first described case of a cutaneous manifestation of long … ER -